Gene · 4920
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bright future or blind alley? CAR-T cell therapy for solid tumors. | Front Immunol | 2023 | 36761757 | PubTator, text mining | PubMed |
| WNT through the Ranks: A Mesenchymal FOXF1-WNT5A Axis Sways Hierarchical Decisions in Alveolar Epithelial Development. | Am J Respir Cell Mol Biol | 2023 | 36730647 | PubTator, text mining | PubMed |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. | Mol Cancer | 2023 | 36717905 | PubTator, text mining | PubMed |
| Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment. | Exp Hematol Oncol | 2023 | 36707873 | PubTator, text mining | PubMed |
| Noncanonical Wnt signaling promotes colon tumor growth, chemoresistance and tumor fibroblast activation. | EMBO Rep | 2023 | 36704936 | PubTator, text mining | PubMed |
| Involvement of redox signalling in tumour cell dormancy and metastasis. | Cancer Metastasis Rev | 2023 | 36701089 | PubTator, text mining | PubMed |
| Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators. | Asian J Androl | 2023 | 36695247 | PubTator, text mining | PubMed |
| Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance. | Int J Mol Sci | 2023 | 36675306 | PubTator, text mining | PubMed |
| Wnt Signaling Pathways: From Inflammation to Non-Melanoma Skin Cancers. | Int J Mol Sci | 2023 | 36675086 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers. | Biomedicines | 2023 | 36672698 | PubTator, text mining | PubMed |
| Wnt4 and ephrinB2 instruct apical constriction via Dishevelled and non-canonical signaling. | Nat Commun | 2023 | 36670115 | PubTator, text mining | PubMed |
| The molecular mechanisms of remodeling in asthma, COPD and IPF with a special emphasis on the complex role of Wnt5A. | Inflamm Res | 2023 | 36658268 | PubTator, text mining | PubMed |
| Large scale phenotype imputation and in vivo functional validation implicate ADAMTS14 as an adiposity gene. | Nat Commun | 2023 | 36658113 | PubTator, text mining | PubMed |
| A versatile Halo- and SNAP-tagged BMP/TGFβ receptor library for quantification of cell surface ligand binding. | Commun Biol | 2023 | 36635368 | PubTator, text mining | PubMed |
| Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non-small-cell lung cancer via Wnt/β-catenin signaling. | Cancer Sci | 2023 | 36625184 | PubTator, text mining | PubMed |
| WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. | Cancer Res | 2023 | 36622276 | PubTator, text mining | PubMed |
| Intravital imaging of Wnt/β-catenin and ATF2-dependent signalling pathways during tumour cell invasion and metastasis. | J Cell Sci | 2023 | 36621522 | PubTator, text mining | PubMed |
| Potential effects of teriparatide (PTH (1-34)) on osteoarthritis: a systematic review. | Arthritis Res Ther | 2023 | 36609338 | PubTator, text mining | PubMed |
| Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end? | J Cancer Res Clin Oncol | 2023 | 36564524 | PubTator, text mining | PubMed |
| DNA methylation profile in the whole blood of acute coronary syndrome patients with aspirin resistance. | J Clin Lab Anal | 2023 | 36550638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4920/papers?page=14